AFYA earnings

Another Year of Strong Performance Guidance Achievement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2025. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2025 Highlights 4Q25 Revenue increased 7.5% YoY to R$913.0 million. Revenue excluding acquisitions increased 7.3%, reaching R$910.8 million. 4Q25 Adjusted EBITDA increased 6.1% YoY, reaching R$388.5 milli

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and nine-month period, which ended September 30, 2025 (third quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2025 Highlights 3Q25 Revenue increased 10.4% YoY to R$928.5 million. Revenue excluding acquisitions increased 10.1%, reaching R$926.2 million.

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highlights 2Q25 Revenue increased 13.5% YoY to R$919.4 million. Revenue excluding acquisitions increased 8.5%, reaching R$879.0 million. 2

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

Impressive Adjusted EBITDA Margin Expansion Robust EPS Expansion Expressive Cash Generation Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and nine-month periods ended September 30, 2024 (third quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2024 Highlights 3Q24 Net Revenue increased 16.3% YoY to R$841.2 million. Net Revenue excluding acquisitions grew 11.8%, reaching R$808.8 million. 3Q24 Ad

Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at: https://ir.afya.com.br/financials/quarterly-earnings/ To participate in Afya's Third Quarter and Nine Months 2024 conference call, please follow

Solid Organic Growth Impressive Adjusted EBITDA Margin Expansion Robust EPS Expansion Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and six-month period, which ended on June 30, 2024 (second quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2024 Highlights 2Q24 Net Revenue increased 13.7% YoY to R$809.9 million. 2Q24 Adjusted EBITDA increased 28.2% YoY reaching R$343.8 million, with an Adjus

Solid Organic Growth Impressive Adjusted EBITDA Margin Expansion Robust EPS Expansion Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2024 Highlights 1Q24 Net Revenue increased 13.3% YoY to R$804.2 million. 1Q24 Adjusted EBITDA increased 20.5% YoY reaching R$397.9 million, with an Adjusted EBITDA Margin of

Another Year of Strong Performance Robust EPS Expansion Guidance Achievement Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2023 Highlights 4Q23 Adjusted Net Revenue increased 22.6% YoY to R$729.5 million. Adjusted Net Revenue excluding acquisitions grew 12.5% to R$669.7 million. 4Q23 Adjusted EBITDA increased 1

Guidance on Track Strong Cash Conversion Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2023 Highlights 3Q23 Adjusted Net Revenue increased 24.6% YoY to R$723.0 million. Adjusted Net Revenue excluding acquisitions grew 13.6%, reaching R$659.0 million. 3Q23 Adjusted EBITDA increased 21.7% YoY, reaching R$278.4 million, w

Afya Limited, or "Afya" (NASDAQ:AFYA, B3: A2FY34))) announced today that will report third-quarter and nine months 2023 financial results for the period ended September 30th, 2023, following the close of the market on Monday, November 13th, 2023 and will host a corresponding conference call and webcast at 05:00 pm EST. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate in Afya's Third Quarter and Nine Months 2023 conference call, please follow the instructions below: Webcast: https://afya.zoom.us/j/97410751315 Dial-in: Brazil: +55 11 4632 2236 or +55 11 4632 2237 or +55 11

High and Predictable Growth Strong Cash Generation Afya Limited (NASDAQ:AFYA, B3: A2FY34))) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2023 Highlights 2Q23 Adjusted Net Revenue increased 23.6% YoY to R$712.2 million. Adjusted Net Revenue excluding acquisitions grew 13.5%, reaching R$654.0 million. 2Q23 Adjusted EBITDA increased 21.8% YoY, reaching R$268.2 milli

Afya Limited, or "Afya" (NASDAQ:AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate in Afya's Second Quarter and First Half 2023 conference call, please follow the instructions below: Webcast: https://afya.zoom.us/j/98725139496 Dial-in: Brazil: +55 21 3958 7888 or +55 11 4632 2236 or +55 11 4632 2237 or +55 11 46

High and Predictable Growth Full Year 2023 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2023 (first quarter 2023). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2023 Highlights 1Q23 Adjusted Net Revenue increased 25.0% YoY to R$709.4 million. Adjusted Net Revenue excluding acquisitions grew 13.5%, reaching R$644.3 million. 1Q23 Adjusted EBITDA increased 21.9% YoY reaching R

Guidance On Track Robust EPS Expansion Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2022 (third quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2022 Highlights 3Q22 Adjusted Net Revenue increased 25.2% YoY to R$580.2 million. Adjusted Net Revenue excluding acquisitions grew 17.1%, reaching R$542.4 million. 3Q22 Adjusted EBITDA increased 19.5% YoY, reaching R$228.7 million,

Afya Limited, or Afya (NASDAQ:AFYA), today announced that it will report Third Quarter and Nine Months 2022 Financial Results for the period ended September 30, 2022, following the close of the market on Monday, November 21st, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate in Afya's Third Quarter and Nine Months 2022 conference call, please follow the instructions below: Webcast: https://afya.zoom.us/j/92548247907 Dial-in: Brazil: +55 11 4700 9668 or +55 21 3958 7888 or +55 11 4632 2236 or +55 11

High and Predictable Growth Strong Net Income Results Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2022 (second quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2022 Highlights 2Q22 Adjusted Net Revenue increased 51.0% YoY to R$576.1 million. Adjusted Net Revenue excluding acquisitions grew 19.0%, reaching R$454.0 million. 2Q22 Adjusted EBITDA increased 37.1% YoY, reaching R$220

Afya Limited, or Afya (NASDAQ:AFYA), today announced that it will report Second-Quarter and First Half 2022 Financial Results for the period ended June 30, 2022, following the close of the market on Monday, August 22nd, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate in Afya's Second-Quarter and First Half 2022 conference call, please follow the instructions below: Webcast: https://afya.zoom.us/j/97592512411 Dial-in: Brazil: +55 21 3958 7888 or +55 11 4632 2236 or +55 11 4632 2237 or +55 11 4680 67

High and Predictable Growth Full Year 2022 Guidance Reaffirmed Robust EPS Expansion Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2022 (first quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2022 Highlights 1Q22 Adjusted Net Revenue increased 41.0% YoY to R$567.7 million. Adjusted Net Revenue excluding acquisitions grew 10.6%, reaching R$445.3 million. 1Q22 Adjusted EBITDA increased 30.

Afya Limited, or Afya (NASDAQ:AFYA), today announced that it will report first-quarter 2022 financial results for the period ended March 31, 2022, following the close of the market on Monday, May 23rd, 2022 and will host a corresponding conference call and webcast at 05:00 pm EDT. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. About Afya: Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong exper

Strong growth Record-High Cash Flow Generation Expansion on Digital Services Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and nine-months period ended September 30, 2021 (third quarter 2021). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2021 Highlights 3Q21 Adjusted Net Revenue increased 47.9% YoY to R$463.3 million. 3Q21 Adjusted EBITDA increased 28.2% YoY reaching R$191.4 million, with an Adjusted EBITDA Margin of 41.3%. Ni

Afya Limited, or Afya (NASDAQ:AFYA), today announced that it will report third quarter 2021 financial results for the period ended September 30, 2021, following the close of the market on Monday, November 22, 2021. The Company will host a corresponding conference call and webcast on November 22 at 05:00 PM EDT. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate on the conference please follow the instructions below: Webcast: https://afya.zoom.us/j/92290972398 Dial-in: Brazil: +55 11 4680 6788 or +55 11 4700 9668 or +55 21 3958 7888 or +55 11 4632 2236 or +55 11 4632 2237 United

Strong Operational Performance High Cash Flow Generation Afya Limited (NASDAQ:AFYA) ("Afya" or the "Company"), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2021 (second quarter 2021). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2021 Highlights 2Q21 Adjusted Net Revenue increased 39.1% YoY to R$381.5 million. Adjusted Net Revenue excluding acquisitions grew 9.0%, reaching R$299.0 million. 2Q21 Adjusted EBITDA increased 36.0% YoY reaching R$16

Afya Limited, or Afya (NASDAQ:AFYA), hereby rectify the press release made on July 19, 2021 and announces that it will report second quarter 2021 financial results for the period ended June 30, 2021, following the close of the market on Thursday, August 26, 2021. The Company will host a corresponding conference call and webcast on August 26 at 05:00 PM EDT. To participate on the conference please follow the instructions below: Webcast: https://afya.zoom.us/j/91787098699 To connect by phone: Brasil: +55 11 4632 2237 or +55 11 4680 6788 or +55 11 4700 9668 or +55 21 3958 7888 or +55 11 4632 2236 United States: +1 929 205 6099 or +1 301 715 8592 or +1 312 626 6799 or +1 669 900 6833 or +

NOVA LIMA, Brazil, July 19, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (NASDAQ:AFYA), today announced that it will report second quarter 2021 financial results for the period ended June 30, 2021, following the close of the market on Thursday, August 26, 2021. The Company will host a corresponding conference call and webcast on August 27 at 11:00 AM EDT. Dialing numbers for the conference will be posted next to the event. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/.   About Afya Limited (NASDAQ:AFYA) Afya is a leading medical education group in Brazil based on number of medica